{"denomUnitsSelected":"Participants","description":"Progression-free survival on the next line of therapy (PFS2) is defined as the time from randomization to progression on the next line of treatment or death, whichever comes first.","reportingStatus":"NOT_POSTED","timeFrame":"From randomization to the clinical cutoff date. Maximum follow up was 54.41 months","title":"Progression-free Survival on the Next Line of Therapy (PFS2)","type":"SECONDARY"}